Enexa Labs is accelerating the time between molecular compositional analysis to clinical trials with our Parallel Pace™ process
At Enexa Labs we seek to normalize the efficacy of plant compounds bridging the gap between naturopathic preparations and the traditional medical space. Through our proprietary process, we scientifically validate plant compound safety and efficacy using our Investigational New Drug (IND) enabling preclinical studies.
Areas of Practice
Real World Evidence
Lowering the human and financial cost of chronic pain with our clinically-validated fully digital remote D2C trials, clients are afforded the opportunity to uncover invaluable consumer insights, experiential and anecdotal data.
Parallel Pace Preclinical Trials
By leveraging data sharing, dual path testing, and time-based milestones, Enexa is facilitating translational science for the next generation of plant-based medicines.
Clinical Trial Readiness
Through our strategic partnerships with elite institutions and leading researchers in the industry, Enexa can guide our clients through clinical trial research and FDA, NHS and Health Canada applications.
Get in Touch
Enexa is your partner in bringing your solution to the people who need it most.